Advertisement

Topics

BRIEF-XOMA says regulatory body in Germany approves plan to conduct repeat-dose clinical study in congenital hyperinsulinism patients over age of 12

05:33 EDT 19 Oct 2016 | Reuters

* Xoma announces significant step toward initiating pediatric phase 2 clinical study for XOMA 358 in children with congenital hyperinsulinism

Original Article: BRIEF-XOMA says regulatory body in Germany approves plan to conduct repeat-dose clinical study in congenital hyperinsulinism patients over age of 12

NEXT ARTICLE

More From BioPortfolio on "BRIEF-XOMA says regulatory body in Germany approves plan to conduct repeat-dose clinical study in congenital hyperinsulinism patients over age of 12"

Quick Search
Advertisement
 

Relevant Topics

Pediatrics
Pediatrics is the general medicine of childhood. Because of the developmental processes (psychological and physical) of childhood, the involvement of parents, and the social management of conditions at home and at school, pediatrics is a specialty. With ...

Congenital Diseases
Congenital conditions are those which are present from birth. They include structural deformities or loss of function in organs such as the <!--LGfEGNT2Lhm-->heart, gut or skeletal system. They can be corrected by <!--LGfEGNT2Lhm-->surgery, m...